Overview
COR market data
Price History
COR price chart · 1M
- O
- 333.25
- H
- 336.01
- L
- 330.26
- C
- 331.00
- Vol
- 66,428.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $333.25
- Previous Close
- $337.03
- Day High
- $336.01
- Day Low
- $330.26
- 52 Week High
- $338.57
- 52 Week Low
- $251.52
- 7 Day Return
- +2.79%
- 30 Day Return
- +4.58%
- 90 Day Return
- +20.96%
- 1 Year Return
- +27.98%
- Daily Notional Volume
- $22M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 24.52 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $7.96 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.59 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $244.82 – $377.54 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $64.4B · P/B 40.18 · P/S 0.19.
Company News
10 captured
Here's Why You Should Retain Cencora Stock in Your Portfolio for NowZacks Investment Research ·
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool ·
Is Generics Still a Quiet Profit Engine for Cardinal Health?Zacks Investment Research ·
Beat the Market the Zacks Way: Accelerant, Insight, General Mills in FocusZacks Investment Research ·
RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330Benzinga ·
8-K filing — Cencora, Inc. (COR)SEC EDGAR ·